Ballerup, Denmark

Johan Eriksson Bajtner


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Johan Eriksson Bajtner

Introduction

Johan Eriksson Bajtner is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents, his work focuses on innovative methods that have the potential to impact medical treatments.

Latest Patents

Johan's latest patents include methods for the preparation of 1,3-benzodioxole heterocyclic compounds. The first patent describes novel methods for synthesizing these compounds, which are recognized for their utility as PDE4 inhibitors. The second patent also pertains to the preparation of 1,3-benzodioxole heterocyclic compounds of formula (I), emphasizing their importance in medicinal chemistry.

Career Highlights

Johan Eriksson Bajtner is currently associated with Union Therapeutics A/S, where he continues to advance his research and development efforts. His work at the company reflects a commitment to innovation in the pharmaceutical industry, particularly in the area of drug discovery and development.

Collaborations

Throughout his career, Johan has collaborated with esteemed colleagues, including Allan Carsten Dahl and Esben Paul Krogh Olsen. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Johan Eriksson Bajtner's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic compounds, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…